Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1992 1
1993 1
1995 1
1996 2
1998 1
1999 6
2000 5
2001 2
2002 1
2003 2
2005 8
2006 7
2007 6
2008 5
2009 5
2010 7
2011 6
2012 11
2013 9
2014 5
2015 7
2016 9
2017 9
2018 10
2019 12
2020 8
2021 10
2022 23
2023 20
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group. Ogo T, et al. Among authors: tsujino i. Eur Respir J. 2022 Jul 7;60(1):2101694. doi: 10.1183/13993003.01694-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34824052 Free PMC article. Clinical Trial.
Adult-onset idiopathic peripheral pulmonary artery stenosis.
Tamura Y, Tamura Y, Shigeta A, Hosokawa K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Nakanishi N, Sato K, Sakamoto J, Tanabe N, Takama N, Nakamura K, Kubota K, Komura N, Kato S, Yamashita J, Takei M, Joho S, Ishii S, Takemura R, Sugimura K, Tatsumi K. Tamura Y, et al. Among authors: tsujino i. Eur Respir J. 2023 Dec 21;62(6):2300763. doi: 10.1183/13993003.00763-2023. Print 2023 Dec. Eur Respir J. 2023. PMID: 38061784 Free PMC article.
Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.
Hosokawa K, Abe K, Funakoshi K, Tamura Y, Nakashima N, Todaka K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Yamashita J, Minatsuki S, Ikeda N, Shimokawahara H, Kawakami T, Ogo T, Hatano M, Ogino H, Fukumoto Y, Tanabe N, Matsubara H, Fukuda K, Tatsumi K, Tsutsui H. Hosokawa K, et al. Among authors: tsujino i. J Thromb Haemost. 2023 Aug;21(8):2151-2162. doi: 10.1016/j.jtha.2023.03.036. Epub 2023 Apr 10. J Thromb Haemost. 2023. PMID: 37044277
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe K; KABUKI Investigators. Hosokawa K, et al. Among authors: tsujino i. Circulation. 2024 Jan 30;149(5):406-409. doi: 10.1161/CIRCULATIONAHA.123.067528. Epub 2023 Nov 13. Circulation. 2024. PMID: 37956127 Free PMC article. Clinical Trial. No abstract available.
Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature.
Nakamura J, Tsujino I, Shima H, Nakaya T, Sugimoto A, Sato T, Watanabe T, Ohira H, Suzuki M, Tsuneta S, Hisada R, Kato M, Konno S. Nakamura J, et al. Among authors: tsujino i. Am J Cardiovasc Drugs. 2023 May;23(3):329-338. doi: 10.1007/s40256-023-00577-6. Epub 2023 Mar 30. Am J Cardiovasc Drugs. 2023. PMID: 36995544 Review.
Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan.
Tamura Y, Kumamaru H, Inami T, Matsubara H, Hirata KI, Tsujino I, Suda R, Miyata H, Nishimura S, Sigel B, Takano M, Tatsumi K; Japan Pulmonary Hypertension Registry (JAPHR) Network. Tamura Y, et al. Among authors: tsujino i. JACC Asia. 2022 May 17;2(3):273-284. doi: 10.1016/j.jacasi.2022.02.011. eCollection 2022 Jun. JACC Asia. 2022. PMID: 36338395 Free PMC article.
SATISFY-JP, a phase II multicenter open-label study on Satralizumab, an anti-IL-6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune-responsive-phenotype: Study protocol.
Tamura Y, Takeyasu R, Takata T, Miyazaki N, Takemura R, Wada M, Tamura Y, Abe K, Shigeta A, Taniguchi Y, Adachi S, Inami T, Tsujino I, Tahara N, Kuwana M. Tamura Y, et al. Among authors: tsujino i. Pulm Circ. 2023 Jun 19;13(2):e12251. doi: 10.1002/pul2.12251. eCollection 2023 Apr. Pulm Circ. 2023. PMID: 37342675 Free PMC article.
176 results